Susquehanna International Group’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.68M | Buy |
105,293
+17,766
| +20% | +$284K | ﹤0.01% | 2501 |
|
|
2025
Q1 | $1.5M | Sell |
87,527
-158,123
| -64% | -$2.7M | ﹤0.01% | 2708 |
|
|
2024
Q4 | $6.08M | Buy |
245,650
+50,343
| +26% | +$1.25M | ﹤0.01% | 982 |
|
|
2024
Q3 | $5.57M | Buy |
195,307
+73,615
| +60% | +$2.1M | ﹤0.01% | 981 |
|
|
2024
Q2 | $3.21M | Sell |
121,692
-121,951
| -50% | -$3.22M | ﹤0.01% | 1322 |
|
|
2024
Q1 | $7.87M | Buy |
243,643
+44,931
| +23% | +$1.45M | ﹤0.01% | 783 |
|
|
2023
Q4 | $8.37M | Buy |
198,712
+82,376
| +71% | +$3.47M | ﹤0.01% | 812 |
|
|
2023
Q3 | $4.47M | Buy |
116,336
+98,521
| +553% | +$3.78M | ﹤0.01% | 1187 |
|
|
2023
Q2 | $338K | Sell |
17,815
-124,214
| -87% | -$2.36M | ﹤0.01% | 4097 |
|
|
2023
Q1 | $2.2M | Buy |
142,029
+120,780
| +568% | +$1.87M | ﹤0.01% | 1849 |
|
|
2022
Q4 | $377K | Buy |
21,249
+8,385
| +65% | +$149K | ﹤0.01% | 3594 |
|
|
2022
Q3 | $72K | Sell |
12,864
-7,554
| -37% | -$42.3K | ﹤0.01% | 5395 |
|
|
2022
Q2 | $80K | Sell |
20,418
-64,913
| -76% | -$254K | ﹤0.01% | 5086 |
|
|
2022
Q1 | $470K | Sell |
85,331
-88,680
| -51% | -$488K | ﹤0.01% | 3800 |
|
|
2021
Q4 | $1.48M | Sell |
174,011
-85,172
| -33% | -$726K | ﹤0.01% | 2333 |
|
|
2021
Q3 | $2.25M | Buy |
259,183
+9,412
| +4% | +$81.8K | ﹤0.01% | 1835 |
|
|
2021
Q2 | $2.64M | Buy |
249,771
+207,373
| +489% | +$2.19M | ﹤0.01% | 1799 |
|
|
2021
Q1 | $680K | Buy |
42,398
+25,043
| +144% | +$402K | ﹤0.01% | 3487 |
|
|
2020
Q4 | $802K | Sell |
17,355
-247
| -1% | -$11.4K | ﹤0.01% | 2849 |
|
|
2020
Q3 | $619K | Buy |
+17,602
| New | +$619K | ﹤0.01% | 2798 |
|